Actavis and Pfizer settle Celebrex litigation

29-04-2014

Actavis and Pfizer settle Celebrex litigation

Photo: Rob Wilson / Shutterstock.com

Actavis has entered into an agreement with Pfizer to settle all outstanding patent litigation related to Pfizer’s arthritis drug Celebrex (celecoxib).


Actavis, Pfizer, Celebrex, patent settlement

More on this story

Pfizer buys Anacor for $5.2bn
18-05-2016

LSIPR